Abstract
Most of the people suffering malaria do not know how complex is that disease and how hard searchers are working to fight against it. Some of these people are dying from malaria while still efficient drug combinations should have save their lives. But these drugs were not available for them when needed, or the diagnosis was wrong, or the drugs were fake, or the doctor was untrained, or the patient had no money. Should this terrible reality preclude the need for continuous research to develop new antimalarial drugs? Should people working in laboratories located in non-endemic countries adapt their project to that reality? Malaria eradication, then elimination was announced and broadcasted in the late sixties, and later forgotten. From that failure due to chloroquine resistance and after decades of less arrogant work, billions of dollars are on the table again to claim this goal. There were bed nets, drugs, vaccine and communication as starters, let’s hope people in endemic countries will be winners.
Keywords: Antimalarial drugs, chemistry, disease, dogma, endemic areas, malaria, patients, plasmodium.
Current Topics in Medicinal Chemistry
Title:New Anti-Malarial Drugs: Who Cares?
Volume: 14 Issue: 14
Author(s): Stephane Picot, Philippe M. Loiseau and Anne-Lise Bienvenu
Affiliation:
Keywords: Antimalarial drugs, chemistry, disease, dogma, endemic areas, malaria, patients, plasmodium.
Abstract: Most of the people suffering malaria do not know how complex is that disease and how hard searchers are working to fight against it. Some of these people are dying from malaria while still efficient drug combinations should have save their lives. But these drugs were not available for them when needed, or the diagnosis was wrong, or the drugs were fake, or the doctor was untrained, or the patient had no money. Should this terrible reality preclude the need for continuous research to develop new antimalarial drugs? Should people working in laboratories located in non-endemic countries adapt their project to that reality? Malaria eradication, then elimination was announced and broadcasted in the late sixties, and later forgotten. From that failure due to chloroquine resistance and after decades of less arrogant work, billions of dollars are on the table again to claim this goal. There were bed nets, drugs, vaccine and communication as starters, let’s hope people in endemic countries will be winners.
Export Options
About this article
Cite this article as:
Picot Stephane, Loiseau M. Philippe and Bienvenu Anne-Lise, New Anti-Malarial Drugs: Who Cares?, Current Topics in Medicinal Chemistry 2014; 14 (14) . https://dx.doi.org/10.2174/1568026614666140808121039
DOI https://dx.doi.org/10.2174/1568026614666140808121039 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma
Current Medicinal Chemistry Role of CT Coronary Angiography in Recanalization of Chronic Total Occlusion
Current Cardiology Reviews Syncytin and GCMa: Key Regulators in Human Placental Physiology and in Pre-Eclampsia
Current Women`s Health Reviews Chromatin Structure and Epigenetics of Tumour Cells: A Review
Cardiovascular & Hematological Disorders-Drug Targets Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Current Drug Targets Acute Actions of Natriuretic Peptides in Coronary Vasculature and Ischaemic Myocardium
Current Pharmaceutical Design Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine
Current Diabetes Reviews Haptoglobin Phenotype Correlates with the Extent of Cerebral Deep White Matter Lesions in Hypertensive Patients
Current Neurovascular Research Isomannide and Derivatives. Chemical and Pharmaceutical Applications
Mini-Reviews in Organic Chemistry Circulating Aminopeptidase Activities in Men and Women with Essential Hypertension
Current Medicinal Chemistry Is there Evidence to Support the Use of Direct Factor Xa Inhibitors in Coronary Artery Disease?
Reviews on Recent Clinical Trials Supplementation of Glutamine and Omega-3 Polyunsaturated Fatty Acids as a Novel Therapeutic Intervention Targeting Metabolic Dysfunction and Exercise Intolerance in Patients with Heart Failure
Current Clinical Pharmacology Monoclonal Antibodies as Innovative Therapeutics
Current Pharmaceutical Biotechnology Special Issue on Stem Cells: An Introduction from the Guest Editor
Current Neurovascular Research Recent Patents in CNS Drug Discovery: The Management of Inflammation in the Central Nervous System
Recent Patents on CNS Drug Discovery (Discontinued) Mitochondrial MMP Activation, Dysfunction and Arrhythmogenesis in Hyperhomocysteinemia
Current Vascular Pharmacology The Genetics of Vascular Complications in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Current Hypertension Reviews Cardioprotection Against Ischemia/Reperfusion Injury and Chromogranin ADerived Peptides
Current Medicinal Chemistry The ONTARGET Trial Programme: Facts and Lessons
Current Hypertension Reviews Catestatin - The Catecholamine Release Inhibitory Peptide: A Structural and Functional Overview
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents